Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Age 0-60 days old~* Late-preterm and term infants (babies born more than 33 weeks and 6 days after the start of the pregnancy)~* History of low blood sugars (hypoglycemia): two episodes of hypoglycemia more than 1 hour apart (low blood sugar will be defined by age: for those less than 48 hours old a low blood sugar is considered less than 50mg/dL and for those older than 48 hours old less than 70mg/dL)~Exclusion Criteria:~* Infants with skin disease such that placement of a glucose sensor under the skin would be difficult to secure~* Infants expected to remain in NICU less than 24 hours~* Infants on a hypothermic protocol~* Infants enrolled in a competing clinical trial~* Family/team have decided to limit or redirect from aggressive NICU technological support~* infants who are wards of the state

- Gender: ALL
- Minimum Age: None
- Maximum Age: 60 Days
- Healthy Volunteers: f

Study Arms:
- CGM Protocol (Type: EXPERIMENTAL): Subjects will receive continuous glucose monitoring and caregivers will be able to view continuous glucose measurements.
- Standard of Care (Type: PLACEBO_COMPARATOR): Subjects will receive continuous glucose monitoring but caregivers will not be able to view continuous glucose measurements.

Based on this trial design, predict the completion outcome and termination type (if applicable).